ALLMedicine™ Melasma Center
Research & Reviews 607 results
https://doi.org/10.1007/s00403-023-02580-y
Archives of Dermatological Research; Abd Elraouf IG, Obaid ZM et. al.
Mar 2nd, 2023 - Millions of people throughout the world suffer from the acquired condition of hyperpigmentation known as melasma. Melasma is characterized by symmetrically oriented hyperpigmented macules and patches. Many treatment options are available with vari...
https://doi.org/10.1007/s00403-023-02584-8
Archives of Dermatological Research; Bostan E, Cakir A
Mar 1st, 2023 - Melasma is an acquired, pigmentary disorder characterized by the appearance of brown to bluish-gray patches with well-demarcated or ill-defined borders, most commonly on the face. This challenging hyperpigmentation disorder is generally observed i...
https://doi.org/10.1111/jocd.15682
Journal of Cosmetic Dermatology; Yin W, Zhao F et. al.
Mar 1st, 2023 - To investigate the molecular mechanism of Croci stigma (CS) in the treatment of melasma by network pharmacology and molecular docking. TCMSP, CTD, STITCH, SymMap, GeneCard, GenBank, OMIM and DrugBank databases were used to obtain the components an...
https://doi.org/10.1111/jocd.15641
Journal of Cosmetic Dermatology; Beyzaee AM, Goldust M et. al.
Feb 28th, 2023 - Melasma is an acquired pigmentary disorder which currently has no definitive treatment. Although topical drugs containing hydroquinone are the basis of treatments, they are usually associated with recurrence. We aimed to evaluate the effectiveness...
https://clinicaltrials.gov/ct2/show/NCT01976286
Feb 21st, 2023 - Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of ...
Drugs 45 results see all →
Clinicaltrials.gov 104 results
https://clinicaltrials.gov/ct2/show/NCT01976286
Feb 21st, 2023 - Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of ...
https://clinicaltrials.gov/ct2/show/NCT05495503
Feb 8th, 2023 - Background: Hyperpigmentation is a problem in all skin types. Safe depigmentation is a challenge. Cryotherapy with liquid nitrogen at -70 °C has been used in the treatment of solar skin lesions for many years but causes considerable damage. Difluo...
https://clinicaltrials.gov/ct2/show/NCT05710068
Feb 2nd, 2023 - Melasma relapse is almost common after discontinuation of conventional treatment. Recent studies have suggested that photoaging dermis is main pathomechanism of melasma emphasizing stromal targeting therapy. Therefore, we investigated maintenance ...
https://clinicaltrials.gov/ct2/show/NCT05119413
Jan 27th, 2023 - Kligman's trio remains the gold standard treatment for melasma. It contain hydroquinone which is an effective anti-melanogenic compound but that has poor tolerance and numerous side-effects. Thiamidol has been proven to be at least as effective as...
https://clinicaltrials.gov/ct2/show/NCT05698342
Jan 26th, 2023 - Melasma is a common, acquired pigmentary disorder characterized by chronic and relapsing hypermelanosis on sun-exposed areas that causes significant emotional and psychosocial impact in patients mainly in women with Fitzpatrick III-V phototypes. T...
News 106 results
https://www.mdedge.com/dermatology/article/260463/pigmentation-disorders/long-term-maintenance-required-melasma-patients
Doug Brunk
Jan 4th, 2023 - SAN DIEGO – When Arisa E. Ortiz, MD, meets with patients who seek treatment for melasma, she tells them that while she can make their hyperpigmentation better, no cure-all exists for the condition.
https://www.mdedge.com/dermatology/article/260462/aesthetic-dermatology/why-its-important-offer-cosmeceuticals-cosmetic
Doug Brunk
Jan 4th, 2023 - SAN DIEGO – While laser procedures, injectables, and chemical peels may be considered the bread and butter of a cosmetic dermatology practice, don’t forget about cosmeceuticals, advised Ava Shamban, MD. Dr.
https://www.mdedge.com/dermatology/article/259988/medical-dermatology/applications-laser-assisted-drug-delivery-horizon
Doug Brunk
Dec 8th, 2022 - For those who view fractional ablative laser–assisted drug delivery as a pie-in-the-sky procedure that will take years to work its way into routine clinical practice, think again. Dr.
https://www.mdedge.com/dermatology/article/259381/pigmentation-disorders/icd-10-code-can-identify-patients-melasma-future
Jeff Craven
Nov 10th, 2022 - To better understand melasma, it is important for researchers to find groups of patients with confirmed disease for future clinical study. A recent research letter published in JAMA Dermatology suggests the ICD-10 code for melasma is a good identi.
https://www.mdedge.com/dermatology/article/257902/aesthetic-dermatology/artemisia-capillaris-extract
Leslie S. Baumann, MD
Sep 16th, 2022 - Melasma is a difficult disorder to treat. With the removal of hydroquinone from the cosmetic market and the prevalence of dyschromia, new skin lightening ingredients are being sought and many new discoveries are coming from Asia.